Jublia FDA Approval History
FDA Approved: Yes (First approved June 6, 2014)
Brand name: Jublia
Generic name: efinaconazole
Dosage form: Topical Solution
Company: Bausch Health Companies Inc.
Treatment for: Onychomycosis, Toenail
Jublia (efinaconazole) is a topical triazole antifungal for the treatment of onychomycosis of the toenails.
Development Timeline for Jublia
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
